Icon

YUPELRI (nda210598)- (175MCG/3ML)

REVEFENACIN MYLAN IRELAND LTD
175MCG/3ML
Yes No
2039-Oct-23 2023-Nov-09
None None
None No
YUPELRI is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
0 0 0
Total Other Developers 14
Drugs with Suitability No
175MCG/3ML ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.